CRP and rheumatoid arthritis: Moreover, D2T-RA patients showed higher rates of ongoing corticosteroid therapy (81.4% vs 34.4%; p < 0.001), higher CRP values [0.66 (0.16 – 1.59) mg/dL vs 0.2 (0.06 – 0.4) mg/dL; p = 0.009], higher TJC-28 [2 (0 -6) vs 0 (0 – 0); p < 0.001] and SJC-28 [1 (0 – 3) vs 0 (0 -0); p < 0.001], higher PGA and NRS0-10 [6 (4 – 7) vs 3 (1.5 – 5); p < 0.001; and 6 (4.25 – 7) vs 3 (0 – 5); p = 0.005, respectively], higher PhGA [2 (0 – 3) vs 0 (0 – 0); p < 0.001], higher SDAI scores (13.8 ± 7.5 vs 4.3 ± 2.8; p < 0.001), and higher HAQ scores [0.75 (0.25 – 1.25) vs 0.375 (0.125 – 0.75); p = 0.027].